---
title: "US FDA gives breakthrough device designation for lipoprotein blood test"
date: "2024-05-24T09:38:50.000Z"
publishedDate: "24 mai 2024"
summary: "Roche has announced that the Tina-quant lipoprotein Lp(a) RxDx assay has received breakthrough device designation from the US Food and Drug Administration (FDA) to identify patients who may benefit from Lp(a)-lowering therapy currently in development. The test has been developed in collaboration with Amgen."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-gives-breakthrough-device-designation-for-lipoprotein-blood-test/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-05-24-us-fda-gives-breakthrough-device-designation-for-lipoprotein-blood-test"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/red-blood-cells-flow-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-gives-breakthrough-device-designation-for-lipoprotein-blood-test/"
---

![US FDA gives breakthrough device designation for lipoprotein blood test](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/red-blood-cells-flow-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-gives-breakthrough-device-designation-for-lipoprotein-blood-test/*

## L’essentiel

Roche has announced that the Tina-quant lipoprotein Lp(a) RxDx assay has received breakthrough device designation from the US Food and Drug Administration (FDA) to identify patients who may benefit from Lp(a)-lowering therapy currently in development. The test has been developed in collaboration with Amgen.

## Lien source

https://cardiovascularnews.com/us-fda-gives-breakthrough-device-designation-for-lipoprotein-blood-test/
